NWBO - Northwest Biotherapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6231,7391,454
Cost of Revenue---
Gross Profit6231,7391,454
Operating Expenses
Research Development60,081103,12085,637
Selling General and Administrative10,86718,32616,960
Non Recurring8,9416,5776,577
Total Operating Expenses---
Operating Income or Loss-79,266-126,284-101,143
Income from Continuing Operations
Total Other Income/Expenses Net2,87015,696-33,495
Earnings Before Interest and Taxes-76,396-110,588-134,638
Interest Expense3,8184,153996
Income Before Tax-80,214-114,741-135,634
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-80,214-114,741-135,634
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-80,214-114,741-135,634
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-85,861-114,741-135,634